Literature DB >> 7852525

Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation.

A Djerassi1, C Coutifaris, V A West, S L Asa, S C Kapoor, S N Pavlou, P J Snyder.   

Abstract

The clinical manifestations of gonadotroph adenomas are almost always neurological, consequences of their large size, and are rarely endocrinological. We report an exception, a 39-yr-old woman whose gonadotroph adenoma caused supranormal serum concentrations of FSH, which resulted in the development of multiple ovarian cysts, persistent elevation of her serum estradiol concentration, and endometrial hyperplasia. She initially presented because of amenorrhea at age 30 yr and was treated for an intrasellar mass by transsphenoidal surgery at age 31 yr and again at age 36 yr. Before and after the second operation she had persistently supranormal plasma estradiol concentrations (> 1840 pmol/L) and endometrial hyperplasia. When she was evaluated at age 39 yr, transvaginal ultrasound showed multiple ovarian cysts and endometrial thickening. Her plasma estradiol level was markedly supranormal (2160 pmol/L), FSH was mildly supranormal (17.8 IU/L), and alpha-subunit was markedly supranormal (23.3 micrograms/L). Characteristic of gonadotroph adenomas, her LH beta level increased by 69% in response to TRH. Neither FSH nor alpha-subunit decreased in response to administration of the GnRH antagonist, Nal-Glu-GnRH (5 mg/12 h for 4 weeks). Excised adenoma tissue exhibited morphological features of a gonadotroph adenoma. This patient appears to be unique, in that her gonadotroph adenoma caused slightly, but persistently, supranormal concentrations of FSH, which caused ovarian stimulation, including supranormal plasma estradiol concentrations, multiple ovarian cysts, and endometrial hyperplasia. We propose that gonadotroph adenomas be considered in the differential diagnosis of patients who have this constellation of abnormalities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852525     DOI: 10.1210/jcem.80.2.7852525

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 2.  Silent (clinically nonfunctioning) pituitary adenomas.

Authors:  Sarah E Mayson; Peter J Snyder
Journal:  J Neurooncol       Date:  2014-03-28       Impact factor: 4.130

Review 3.  Endocrine inactive and gonadotroph adenomas: diagnosis and management.

Authors:  M Losa; P Mortini; R Barzaghi; A Franzin; M Giovanelli
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

4.  Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.

Authors:  Amelia Caretto; Roberto Lanzi; Cecilia Piani; Michela Molgora; Pietro Mortini; Marco Losa
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

5.  FOLLICLE-STIMULATING HORMONE-PRODUCING PITUITARY ADENOMA: A CASE REPORT AND REVIEW OF THE LITERATURE.

Authors:  Sonal Patel; Donato Pacione; Ilene Fischer; Ekrem Maloku; Nidhi Agrawal
Journal:  AACE Clin Case Rep       Date:  2019-04-25

6.  Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome.

Authors:  Sayaka Uchida; Hiroshi Uchida; Tetsuo Maruyama; Takashi Kajitani; Hideyuki Oda; Kaoru Miyazaki; Maki Kagami; Yasunori Yoshimura
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

7.  Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman--latent risk of unidentified ovarian hyperstimulation: a case report.

Authors:  Tomohiro Kawaguchi; Yoshikazu Ogawa; Kenji Ito; Mika Watanabe; Teiji Tominaga
Journal:  BMC Res Notes       Date:  2013-10-11

8.  Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using In Vitro Fertilization and Embryo Transfer: A Case Report.

Authors:  Xiaofang Du; Wen Zhang; Xingling Wang; Xiaona Yu; Zhen Li; Yichun Guan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

9.  Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome.

Authors:  Mika Kanaya; Tsuyoshi Baba; Yoshimitsu Kitajima; Keiko Ikeda; Ayumi Shimizu; Miyuki Morishita; Hiroyuki Honnma; Toshiaki Endo; Tsuyoshi Saito
Journal:  Int J Womens Health       Date:  2012-08-24

10.  An FSH and TSH pituitary adenoma, presenting with precocious puberty and central hyperthyroidism.

Authors:  Guadalupe Vargas; Lourdes-Josefina Balcazar-Hernandez; Virgilio Melgar; Roser-Montserrat Magriña-Mercado; Baldomero Gonzalez; Javier Baquera; Moisés Mercado
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.